Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov;26(11):1971-1983.
doi: 10.1038/s41556-024-01508-6. Epub 2024 Sep 12.

Solid tumour-induced systemic immunosuppression involves dichotomous myeloid-B cell interactions

Affiliations

Solid tumour-induced systemic immunosuppression involves dichotomous myeloid-B cell interactions

Xiaoxin Hao et al. Nat Cell Biol. 2024 Nov.

Abstract

Solid tumours induce systemic immunosuppression that involves myeloid and T cells. B cell-related mechanisms remain relatively understudied. Here we discover two distinct patterns of tumour-induced B cell abnormality (TiBA; TiBA-1 and TiBA-2), both associated with abnormal myelopoiesis in the bone marrow. TiBA-1 probably results from the niche competition between pre-progenitor-B cells and myeloid progenitors, leading to a global reduction in downstream B cells. TiBA-2 is characterized by systemic accumulation of a unique early B cell population, driven by interaction with excessive neutrophils. Importantly, TiBA-2-associated early B cells foster the systemic accumulation of exhaustion-like T cells. Myeloid and B cells from the peripheral blood of patients with triple-negative breast cancer recapitulate the TiBA subtypes, and the distinct TiBA profile correlates with pathologic complete responses to standard-of-care immunotherapy. This study underscores the inter-patient diversity of tumour-induced systemic changes and emphasizes the need for treatments tailored to different B and myeloid cell abnormalities.

PubMed Disclaimer

Conflict of interest statement

Competing interests The authors declare no competing interests.

References

    1. McAllister SS & Weinberg RA The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nature Cell Biology 16, 717–727 (2014). 10.1038/ncb3015 - DOI - PMC - PubMed
    1. Hiam-Galvez KJ, Allen BM & Spitzer MH Systemic immunity in cancer. Nat Rev Cancer 21, 345–359 (2021). 10.1038/s41568-021-00347-z - DOI - PMC - PubMed
    1. Castano Z, Tracy K & McAllister SS The tumor macroenvironment and systemic regulation of breast cancer progression. Int J Dev Biol 55, 889–897 (2011). 10.1387/ijdb.113366zc - DOI - PubMed
    1. Jaillon S et al. Neutrophil diversity and plasticity in tumour progression and therapy. Nat Rev Cancer 20, 485–503 (2020). 10.1038/s41568-020-0281-y - DOI - PubMed
    1. Gabrilovich DI & Nagaraj S Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9, 162–174 (2009). 10.1038/nri2506 - DOI - PMC - PubMed

METHOD-ONLY REFERENCE

    1. Stuart T et al. Comprehensive Integration of Single-Cell Data. Cell 177, 1888–1902 e1821 (2019). 10.1016/j.cell.2019.05.031 - DOI - PMC - PubMed
    1. Hafemeister C & Satija R Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol 20, 296 (2019). 10.1186/s13059-019-1874-1 - DOI - PMC - PubMed
    1. Browaeys R, Saelens W & Saeys Y NicheNet: modeling intercellular communication by linking ligands to target genes. Nat Methods 17, 159–162 (2020). 10.1038/s41592-019-0667-5 - DOI - PubMed
    1. Wu T et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. The Innovation 2, 100141 (2021). 10.1016/j.xinn.2021.100141 - DOI - PMC - PubMed
    1. Yu G, Wang L-G, Han Y & He Q-Y clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters. OMICS: A Journal of Integrative Biology 16, 284–287 (2012). 10.1089/omi.2011.0118 - DOI - PMC - PubMed

MeSH terms